347 related articles for article (PubMed ID: 18443558)
1. Prognostic value of computer-assisted morphological and morphometrical analysis for detecting the recurrence tendency of basal cell carcinoma.
Cheretis C; Angelidou E; Dietrich F; Politi E; Kiaris H; Koutselini H
Med Sci Monit; 2008 May; 14(5):MT13-19. PubMed ID: 18443558
[TBL] [Abstract][Full Text] [Related]
2. Comparative morphometric analysis of primary versus recurrent basal cell carcinoma and of histological subtypes. Significance of morphometry of the nuclei.
Bierhoff E; Appel K; Appel T; Buettner R; Wardelmann E
Anticancer Res; 2003; 23(3B):2697-700. PubMed ID: 12894560
[TBL] [Abstract][Full Text] [Related]
3. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
4. Recurrent morphean basal cell carcinoma of the skin. A clinico-histopathological study of 97 cases.
Anthouli-Anagnostopoulou F; Hatziolou E
Adv Clin Path; 2002 Jan; 6(1):17-24. PubMed ID: 17582944
[TBL] [Abstract][Full Text] [Related]
5. Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions.
Boulinguez S; Grison-Tabone C; Lamant L; Valmary S; Viraben R; Bonnetblanc JM; Bédane C
Br J Dermatol; 2004 Sep; 151(3):623-6. PubMed ID: 15377349
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of basal cell carcinomas: an audit of current practice.
Mc Loone NM; Tolland J; Walsh M; Dolan OM
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):698-701. PubMed ID: 16836498
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
[TBL] [Abstract][Full Text] [Related]
8. Predictive variables for the biological behaviour of basal cell carcinoma of the face: relevance of morphometry of the nuclei.
Appel T; Bierhoff E; Appel K; von Lindern JJ; Bergé S; Niederhagen B
Br J Oral Maxillofac Surg; 2003 Jun; 41(3):147-50. PubMed ID: 12804537
[TBL] [Abstract][Full Text] [Related]
9. Computer analysis of normal and basal cell carcinoma mast cells.
Janowski P; Strzelecki M; Brzezińska-Błaszczyk E; Zalewska A
Med Sci Monit; 2001; 7(2):260-5. PubMed ID: 11257733
[TBL] [Abstract][Full Text] [Related]
10. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
11. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
[TBL] [Abstract][Full Text] [Related]
12. Perianal and genital basal cell carcinoma: A clinicopathologic review of 51 cases.
Gibson GE; Ahmed I
J Am Acad Dermatol; 2001 Jul; 45(1):68-71. PubMed ID: 11423837
[TBL] [Abstract][Full Text] [Related]
13. The effect of 595 nm pulsed dye laser on superficial and nodular basal cell carcinomas.
Shah SM; Konnikov N; Duncan LM; Tannous ZS
Lasers Surg Med; 2009 Aug; 41(6):417-22. PubMed ID: 19588534
[TBL] [Abstract][Full Text] [Related]
14. Nuclear morphometry lacks prognostic value in squamous cell carcinoma of the oesophagus.
Rodríguez Sanjuán JC; Val Bernal F; Blanco García C; García-Castrillo Riesgo L
Histol Histopathol; 1993 Jul; 8(3):505-8. PubMed ID: 8358161
[TBL] [Abstract][Full Text] [Related]
15. Nucleomorphometric analysis of feline basal cell carcinomas.
Simeonov R; Simeonova G
Res Vet Sci; 2008 Jun; 84(3):440-3. PubMed ID: 17706734
[TBL] [Abstract][Full Text] [Related]
16. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
Lawrence CM; Haniffa M; Dahl MG
Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of basal cell carcinoma.
Hakverdi S; Balci DD; Dogramaci CA; Toprak S; Yaldiz M
Indian J Dermatol Venereol Leprol; 2011; 77(2):251. PubMed ID: 21393972
[TBL] [Abstract][Full Text] [Related]
18. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
[TBL] [Abstract][Full Text] [Related]
19. In vivo optical coherence tomography of basal cell carcinoma.
Gambichler T; Orlikov A; Vasa R; Moussa G; Hoffmann K; Stücker M; Altmeyer P; Bechara FG
J Dermatol Sci; 2007 Mar; 45(3):167-73. PubMed ID: 17215110
[TBL] [Abstract][Full Text] [Related]
20. Findings of computerized nuclear morphometry of papillary thyroid carcinoma in correlation with the age of the patients.
Tseleni S; Kavantzas N; Yova D; Alexandratou E; loannou-Lambrouli M; Paraskevakou H; Davaris P
Gen Diagn Pathol; 1997 Jul; 143(1):23-7. PubMed ID: 9269905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
